A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a chemotherapy regimen doubled the survival of patients with late-stage ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

A University of Iowa Health Care randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage ...

The study showed that patients receiving high-dose vitamin C had longer progression-free survival and nearly doubled overall survival rates, from 8.3 months in the standard care group to 16 months ...

Supplements are part of the daily routine for over half of adults in the United States. However, they aren't regulated in ...

Vitamin C is usually well tolerated, although high doses can cause diarrhea, nausea, and stomach cramps. ... What should I do if I miss a dose of a vitamin C supplement?

Vitamin C is an immune-boosting superhero. It’s also a nutrient that the body doesn’t make (unlike vitamin D), so you need to ...

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing ...